Premium
DECITABINE PLUS R‐CHOP IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE LARGE B‐CELL LYMPHOMA: INTERIM RESULTS OF A PHASE I/II STUDY
Author(s) -
Zhang M.,
Xu P.,
Cheng S.,
Wang L.,
Zhao W.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.212_2631
Subject(s) - decitabine , diffuse large b cell lymphoma , medicine , international prognostic index , oncology , chemotherapy regimen , chop , febrile neutropenia , lymphoma , vincristine , chemotherapy , neutropenia , gastroenterology , dna methylation , cyclophosphamide , biology , biochemistry , gene expression , gene
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom